August 3, 2017 / 9:01 PM / 2 years ago

BRIEF-Cara Therapeutics Q2 loss per share $0.29

Aug 3 (Reuters) - Cara Therapeutics Inc:

* Cara Therapeutics reports second quarter 2017 financial results

* Q2 loss per share $0.29

* Q2 earnings per share view $-0.62 — Thomson Reuters I/B/E/S

* Cara-‍ expects existing cash, cash equivalents, available-for-sale marketable securities to be sufficient to fund operating expenses, capex requirements into 2019​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below